Education platform Knowbox has received a new round of funding to develop cost-saving AI technology, but with regulations tightening, time is running out for these platforms to generate positive cash flows.
Biocytogen delivers gene-modified mice to speed up development in the pharmaceutical industry. Riding the momentum of biotech development in China, the firm expects to IPO within three years.
Following a year of mega IPO flops, Chinese VC investment plummeted in the second quarter as private investors baulked at spiralling valuations. Staying private for longer will no longer be so easy for entrepreneurs.